These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, Yong D, Chong Y. Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308 [Abstract] [Full Text] [Related]
24. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses. Vo AT, van Duijkeren E, Fluit AC, Gaastra W. Vet Microbiol; 2007 Oct 06; 124(3-4):248-55. PubMed ID: 17521833 [Abstract] [Full Text] [Related]
25. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae. Palasubramaniam S, Subramaniam G, Muniandy S, Parasakthi N. Microb Drug Resist; 2007 Oct 06; 13(3):186-90. PubMed ID: 17949305 [Abstract] [Full Text] [Related]
26. [Identification and expression of blaCTX-M-14 and blaCTX-M-24]. Xiong ZZ, Zhu DM, Wang F, Zhang YY. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1454-9. PubMed ID: 15500745 [Abstract] [Full Text] [Related]
27. [Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles]. Oksüz L, Gürler N. Mikrobiyol Bul; 2009 Apr 02; 43(2):183-94. PubMed ID: 19621602 [Abstract] [Full Text] [Related]
28. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D. Microb Drug Resist; 2010 Mar 02; 16(1):49-53. PubMed ID: 19961397 [Abstract] [Full Text] [Related]
29. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Yang J, Ye L, Wang W, Luo Y, Zhang Y, Han L. Int J Antimicrob Agents; 2011 Oct 02; 38(4):348-51. PubMed ID: 21724374 [Abstract] [Full Text] [Related]
30. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Lee K, Yong D, Choi YS, Yum JH, Kim JM, Woodford N, Livermore DM, Chong Y. Int J Antimicrob Agents; 2007 Feb 02; 29(2):201-6. PubMed ID: 17204406 [Abstract] [Full Text] [Related]
31. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae]. Coşkun S, Altanlar N. Mikrobiyol Bul; 2012 Jul 02; 46(3):375-85. PubMed ID: 22951650 [Abstract] [Full Text] [Related]
32. Co-production of SFO-1 and DHA-1 β-lactamases and 16S rRNA methylase ArmA in clinical isolates of Klebsiella pneumoniae. Guo Q, Wang P, Ma Y, Yang Y, Ye X, Wang M. J Antimicrob Chemother; 2012 Oct 02; 67(10):2361-6. PubMed ID: 22778158 [Abstract] [Full Text] [Related]
34. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae]. Wang QT, Liu YM, Wang H, Sun HL, Chen MJ, Du XL. Zhonghua Nei Ke Za Zhi; 2004 Jul 02; 43(7):487-90. PubMed ID: 15312399 [Abstract] [Full Text] [Related]
40. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center. Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S. P R Health Sci J; 2004 Sep 02; 23(3):207-15. PubMed ID: 15631176 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]